Your browser does not support JavaScript capabilities, which maybe required to display this page properly.


PDF FormatRequires Adobe Acrobat Reader

Data Tables


Sections I - VIII
I. Summary Tables
II. Deceased and Living Donor Characteristics
III. Deceased Donor Organ Recovery and Disposition
IV. Organ Procurement Organization Tables
V. Kidney Tables
VI. Pancreas Transplant Alone (PTA) Tables
VII. Pancreas After Kidney (PA k) Tables
VIII. Kidney-Pancreas Tables
Sections IX - XV
IX. Liver Tables
X. Intestine Tables
XI. Heart Tables
XII. Lung Tables
XIII. Heart-Lung Tables
XIV. Donor and Recipient Tumor Tables
XV. Supplementary Tables
  Technical Notes and Analytic Methods



View HTML View PDF

Section I
1.1 U.S. Organ Donors by Organ and Donor Type, 1998 to 2007 Table 1.1(36 k)
1.2 Number of Organs Recovered from Deceased Donors, 1998 to 2007 Table 1.2(32 k)
1.3 Waiting List at End of Year, 1998 to 2007 Table 1.3(34 k)
1.4 Characteristics of Waiting List Patients at End of Year, 1998 to 2007 Table 1.4(62 k)
Age
Blood Type
Residency
Gender
Previous Transplant Any Organ
Race
Patient Status
1.5 Time to Transplant New Waiting List Registrations, 1998 to 2007 Table 1.5(91 k)
1.6 Reported Deaths and Annual Death Rates Per 1,000 Patient-Years at Risk Waiting List, 1998 to 2007 Table 1.6(37 k)
1.7 Transplants by Organ and Donor Type, 1998 to 2007 Table 1.7(42 k)
1.8 Multi-Organ Transplants, 1998 to 2007 Table 1.8(33 k)
1.9a Immunosuppression Use by Organ in 2006 and 2007 Table 1.9a(42 k)
1.9b Immunosuppression Use by Organ Maintenance Regimen at Discharge, 2007 Transplants Table 1.9b(38 k)
1.9c Immunosuppression Use by Organ Maintenance Regimen at One Year Following Transplantation 2006 Transplants Table 1.9c(38 k)
1.10 Transplant Recipient Characteristics, 1998 to 2007 Table 1.10(46 k)
Blood Type
Residency
Gender
Race
Age
Previous Transplant Any Organ
Payment Source
1.11a One Year Adjusted Graft Survival by Organ and Year of Transplant, 1997 to 2006 Table 1.11a(38 k)
1.11b One Year Unadjusted Graft Survival by Organ and Year of Transplant, 1997 to 2006 Table 1.11b(38 k)
1.12a One Year Adjusted Patient Survival by Organ and Year of Transplant, 1997 to 2006 Table 1.12a(38 k)
1.12b One Year Unadjusted Patient Survival by Organ and Year of Transplant, 1997 to 2006 Table 1.12b(39 k)
1.13 Unadjusted Graft and Patient Survival at 3 Months, 1 Year, 3 Years, 5 Years, and 10 Years Standard Errors of the Survival Rates Table 1.13(48 k)
Standard Errors of the Survival Rates
Survival (%)
Number of Transplants For This Survival Analysis
1.14 Prevalence of People Living with a Functioning Transplant at End of Year 1998 to 2006 Table 1.14(27 k)

Section II
2.1 Deceased Donor Characteristics, 1998 to 2007 Deceased Donors of Any Organ Table 2.1(61 k)
Age
Blood Type
Cause of Death
Circumstance of Death
Mechanism of Death
Gender
Donation After Cardiac Death
Race
2.2 Deceased Donor Characteristics, 1998 to 2007 Kidney Donors Table 2.2(61 k)
Age
Blood Type
Cause of Death
Circumstance of Death
Mechanism of Death
Gender
Race
Donor Category(ECD, SCD, DCD)
2.3 Deceased Donor Characteristics, 1998 to 2007 Pancreas Donors Table 2.3(61 k)
Age
Blood Type
Cause of Death
Circumstance of Death
Mechanism of Death
Gender
Donation After Cardiac Death
Race
2.4 Deceased Donor Characteristics, 1998 to 2007 Liver Donors Table 2.4(61 k)
Age
Blood Type
Cause of Death
Circumstance of Death
Mechanism of Death
Gender
Donation After Cardiac Death
Race
2.5 Deceased Donor Characteristics, 1998 to 2007 Intestine Donors Table 2.5(60 k)
Age
Blood Type
Cause of Death
Circumstance of Death
Mechanism of Death
Gender
Donation After Cardiac Death
Race
2.6 Deceased Donor Characteristics, 1998 to 2007 Heart Donors Table 2.6(60 k)
Age
Blood Type
Cause of Death
Circumstance of Death
Mechanism of Death
Gender
Race
2.7 Deceased Donor Characteristics, 1998 to 2007 Lung Donors Table 2.7(61 k)
Age
Blood Type
Cause of Death
Circumstance of Death
Mechanism of Death
Gender
Donation After Cardiac Death
Race
2.8 Living Donor Characteristics, 1998 to 2007 Living Donors of Any Organ Table 2.8(46 k)
Age
Blood Type
Gender
Race
Donor Relation
2.9 Living Donor Characteristics, 1998 to 2007 Kidney Donors Table 2.9(46 k)
Age
Blood Type
Gender
Race
Donor Relation
2.10 Living Donor Characteristics, 1998 to 2007 Liver Segment Donors Table 2.10(45 k)
Age
Blood Type
Gender
Race
Donor Relation
2.11 Living Donor Characteristics, 1998 to 2007 Lung Lobe Donors Table 2.11(44 k)
Age
Blood Type
Gender
Race
Donor Relation
2.12 Deceased Donor Organ Utilization, 1998 to 2007, Any Organ Table 2.12(72 k)
2.13 Deceased Donor Organ Utilization, 1998 to 2007, Kidney Table 2.13(80 k)
2.14 Deceased Donor Organ Utilization, 1998 to 2007, Pancreas Table 2.14(83 k)
2.15 Deceased Donor Organ Utilization, 1998 to 2007, Liver Table 2.15(105 k)
2.16 Deceased Donor Organ Utilization, 1998 to 2007, Intestine Table 2.16(47 k)
2.17 Deceased Donor Organ Utilization, 1998 to 2007, Heart Table 2.17(70 k)
2.18 Deceased Donor Organ Utilization, 1998 to 2007, Lung Table 2.18(70 k)

Section III
3.1 Disposition of Organs Recovered from Deceased Donors, 1998 to 2007 Kidney Table 3.1(35 k)
3.2 Reasons for Non-Use of Recovered Organs, 1998 to 2007 Kidney Table 3.2(37 k)
3.3 Reasons for Non-Recovery of Consented Organs, 1998 to 2007 Kidney Table 3.3(37 k)
3.4 Disposition of Organs Recovered from Deceased Donors, 1998 to 2007 Pancreas Table 3.4(33 k)
3.5 Reasons for Non-Use of Recovered Organs, 1998 to 2007 Pancreas Table 3.5(36 k)
3.6 Reasons for Non-Recovery of Consented Organs, 1998 to 2007 Pancreas Table 3.6(37 k)
3.7 Disposition of Organs Recovered from Deceased Donors, 1998 to 2007 Liver Table 3.7(35 k)
3.8 Reasons for Non-Use of Recovered Organs, 1998 to 2007 Liver Table 3.8(37 k)
3.9 Reasons for Non-Recovery of Consented Organs, 1998 to 2007 Liver Table 3.9(36 k)
3.10 Disposition of Organs Recovered from Deceased Donors, 1998 to 2007 Intestine Table 3.10(34 k)
3.11 Reasons for Non-Use of Recovered Organs, 1998 to 2007 Intestine Table 3.11(37 k)
3.12 Reasons for Non-Recovery of Consented Organs, 1998 to 2007 Intestine Table 3.12(37 k)
3.13 Disposition of Organs Recovered from Deceased Donors, 1998 to 2007 Heart Table 3.13(35 k)
3.14 Reasons for Non-Use of Recovered Organs, 1998 to 2007 Heart Table 3.14(37 k)
3.15 Reasons for Non-Recovery of Consented Organs, 1998 to 2007 Heart Table 3.15(37 k)
3.16 Disposition of Organs Recovered from Deceased Donors, 1998 to 2007 Lung Table 3.16(35 k)
3.17 Reasons for Non-Use of Recovered Organs, 1998 to 2007 Lung Table 3.17(37 k)
3.18 Reasons for Non-Recovery of Consented Organs, 1998 to 2007 Lung Table 3.18(37 k)

Section IV
4.1 Deceased Donors Procured by U.S. Organ Procurement Organizations 1998 to 2007 Table 4.1(64 k)
4.2 Transplant Centers Within Each OPO CMS-Designated Service Area As of May 2008, By Home State of OPO Table 4.2(127 k)

Section V
5.1a Waiting List Patient Characteristics at End of Year Kidney Waiting List Active Waitlist Patients, 1998 to 2007 Table 5.1a(58 k)
Age
Blood Type
Residency
Diagnosis
Gender
Previous Transplant Any Organ
Race
PRA
Previous Transplant Same Organ
Time on Waiting List
5.1b Waiting List Patient Characteristics at End of Year Kidney Waiting List Inactive Waitlist Patients, 1998 to 2007 Table 5.1b(58 k)
Age
Blood Type
Residency
Diagnosis
Gender
Previous Transplant Any Organ
Race
PRA
Previous Transplant Same Organ
Time on Waiting List
5.2 Time to Transplant, 1998 to 2007 New Kidney Waiting List Registrations Table 5.2(186 k)
Blood Type
Age
Gender
All Patient Types
PRA
Gender and PRA
Race and PRA
Previous Transplant Any Organ
Previous Transplant and Gender
Previous Transplant and PRA
Previous Transplant and Race
Race
Residency
State of Center
5.3 Reported Deaths and Annual Death Rates Per 1,000 Patient-Years at Risk, 1998 to 2007 Kidney Waiting List Table 5.3(63 k)
Age
Blood Type
Diagnosis
Gender
Race
5.4 Transplant Recipient Characteristics, 1998 to 2007 Recipients of Deceased Donor Kidneys Table 5.4(54 k)
5.4a Transplant Recipient Characteristics, 1998 to 2007 Recipients of Deceased Donor non-ECD Kidneys Table 5.4a(126 k)
Age
Blood Type
Residency
Gender
PRA
Race
Diagnosis
Cold Ischemic Time
Hospitalized at Tx
Level of HLA Mismatch
PRA
Previous Transplant Same Organ
Previous Transplant Any Organ
Payment Source
5.4b Transplant Recipient Characteristics, 1998 to 2007 Recipients of Deceased Donor Expanded Criteria Donors (ECD) Kidneys Table 5.4b(124 k)
Age
Blood Type
Residency
Gender
PRA
Race
Diagnosis
Cold Ischemic Time
Hospitalized at Tx
Level of HLA Mismatch
PRA
Previous Transplant Same Organ
Previous Transplant Any Organ
Payment Source
5.4c Transplant Recipient Characteristics, 1998 to 2007 Recipients of Deceased Donor Kidneys Table 5.4c(126 k)
Age
Blood Type
Residency
Gender
PRA
Race
Diagnosis
Cold Ischemic Time
Hospitalized at Tx
Level of HLA Mismatch
PRA
Previous Transplant Same Organ
Previous Transplant Any Organ
Payment Source
5.4d Transplant Recipient Characteristics, 1998 to 2007 Recipients of Living Donor Kidneys Table 5.4d(120 k)
Age
Blood Type
Residency
Gender
PRA
Race
Donor Relation
Diagnosis
Hospitalized at Tx
Level of HLA Mismatch
PRA
Previous Transplant Same Organ
Previous Transplant Any Organ
Payment Source
5.5 Incidence of Transplant, 1998 to 2007 Kidney Transplants per 1 Million Population Table 5.5(169 k)
5.6a Immunosuppression Use for Induction, 1998 to 2007 Recipients with Kidney Transplants Table 5.6a(61 k)
5.6b Immunosuppression Use for Induction by Discharge Regimen, 2003 to 2007 Recipients with Kidney Transplants Table 5.6b(47 k)
5.6c Immunosuppression Use for Induction by Steroid Use at Discharge, 2003 to 2007 Recipients with Kidney Transplants Table 5.6c(47 k)
5.6d Immunosuppression Use for Maintenance by Regimen Prior to Discharge, 1998 to 2007 Recipients with Kidney Transplants Table 5.6d(37 k)
5.6e Immunosuppression Use for Maintenance Prior to Discharge, 1998 to 2007 Recipients with Kidney Transplants Table 5.6e(61 k)
5.6f Immunosuppression Use for Maintenance by Regimen One Year Following Transplantation, 1997 to 2006 Recipients with Kidney Transplants Table 5.6f(39 k)
5.6g Immunosuppression Use for Maintenance Between Discharge and One Year Following Transplantation, 1997 to 2006 Recipients with Kidney Transplants Table 5.6g(61 k)
5.6h Persistency of Discharge Regimen by Follow-up Period, 2002 to 2006 Recipients with Kidney Transplants Table 5.6h(153 k)
5.6i Immunosuppression Use for Antirejection Treatment from Transplant to One Year Following Transplantation, 1997 to 2006 Recipients with Kidney Transplants Table 5.6i(63 k)
5.7a Patients and Annual Death Rates Per 1,000 Patient-Years at Risk, 1998 to 2006 Rates for Recipients during First Year after Deceased Donor non-ECD Kidney Transplantation Table 5.7a(201 k)
Blood Type
Residency
Gender
PRA
Race
Donor Age
Previous Transplant
Age
Cold Ischemic Time
Hospitalized at Tx
Level of HLA Mismatch
Diagnosis
State of Center
5.7b Patients and Annual Death Rates Per 1,000 Patient-Years at Risk, 1998 to 2006 Rates for Recipients during First Year after Deceased Donor ECD Kidney Transplantation Table 5.7b(177 k)
Blood Type
Residency
Gender
PRA
Race
Donor Age
Previous Transplant
Age
Cold Ischemic Time
Hospitalized at Tx
Level of HLA Mismatch
Diagnosis
State of Center
5.7c Patients and Annual Death Rates Per 1,000 Patient-Years at Risk, 1998 to 2006 Rates for Recipients during First Year after Deceased Donor Kidney Transplantation Table 5.7c(204 k)
Blood Type
Residency
Gender
PRA
Race
Donor Age
Previous Transplant
Age
Cold Ischemic Time
Hospitalized at Tx
Level of HLA Mismatch
Diagnosis
State of Center
5.7d Patients and Annual Death Rates Per 1,000 Patient-Years at Risk, 1998 to 2006 Rates for Recipients during First Year after Living Donor Kidney Transplantation Table 5.7d(270 k)
Blood Type
Residency
Gender
PRA
Race
Donor Age
Previous Transplant
Age
Hospitalized at Tx
Level of HLA Mismatch
Diagnosis
State of Center
5.8a Adjusted Graft Survival, Deceased Donor non-ECD Kidney Transplants Survival at 3 Months, 1 Year, 5 Years, and 10 Years Table 5.8a(59 k)
Age
Gender
Race
Diagnosis
State of Center
5.8b Adjusted Graft Survival, Deceased Donor ECD Kidney Transplants Survival at 3 Months, 1 Year, 5 Years, and 10 Years Table 5.8b(59 k)
Age
Gender
Race
Diagnosis
State of Center
5.8c Adjusted Graft Survival, Deceased Donor Kidney Transplants Survival at 3 Months, 1 Year, 5 Years, and 10 Years Table 5.8c(58 k)
Age
Gender
Race
Diagnosis
State of Center
5.8d Adjusted Graft Survival, Living Donor Kidney Transplants Survival at 3 Months, 1 Year, 5 Years, and 10 Years Table 5.8d(58 k)
Age
Gender
Race
Diagnosis
State of Center
5.9a Adjusted Graft Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Deceased Donor non-ECD Kidney Transplants Table 5.9a(31 k)
5.9b Adjusted Graft Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Deceased Donor ECD Kidney Transplants Table 5.9b(31 k)
5.9c Adjusted Graft Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Deceased Donor Kidney Transplants Table 5.9c(30 k)
5.9d Adjusted Graft Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Living Donor Kidney Transplants Table 5.9d(30 k)
5.10a Unadjusted Graft Survival, Deceased Donor non-ECD Kidney Transplants Survival at 3 Months, 1 Year, 5 Years, and 10 Years Table 5.10a(104 k)
Age
Blood Type
Residency
Gender
PRA
Race
Center Volume
Donor Age
Previous Transplant Same Organ
Diagnosis
Dialysis Within 1 Week of Tx
Cold Ischemic Time
On Life Support at Tx
Hospitalized at Tx
Level of HLA Mismatch
State of Center
5.10b Unadjusted Graft Survival, Deceased Donor ECD Kidney Transplants Survival at 3 Months, 1 Year, 5 Years, and 10 Years Table 5.10b(81 k)
Age
Blood Type
Residency
Gender
PRA
Race
Center Volume
Donor Age
Previous Transplant Same Organ
Diagnosis
Dialysis Within 1 Week of Tx
Cold Ischemic Time
On Life Support at Tx
Hospitalized at Tx
Level of HLA Mismatch
State of Center
5.10c Unadjusted Graft Survival, Deceased Donor Kidney Transplants Survival at 3 Months, 1 Year, 5 Years, and 10 Years Table 5.10c(104 k)
Age
Blood Type
Residency
Gender
PRA
Race
Center Volume
Donor Age
Previous Transplant Same Organ
Diagnosis
Dialysis Within 1 Week of Tx
Cold Ischemic Time
On Life Support at Tx
Hospitalized at Tx
Level of HLA Mismatch
State of Center
5.10d Unadjusted Graft Survival, Living Donor Kidney Transplants Survival at 3 Months, 1 Year, 5 Years, and 10 Years Table 5.10d(102 k)
Age
Blood Type
Residency
Gender
PRA
Race
Center Volume
Donor Relation
Donor Age
Previous Transplant Same Organ
Diagnosis
Dialysis Within 1 Week of Tx
On Life Support at Tx
Hospitalized at Tx
Level of HLA Mismatch
State of Center
5.11a Unadjusted Graft Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Deceased Donor non-ECD Kidney Transplants Table 5.11a(31 k)
5.11b Unadjusted Graft Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Deceased Donor ECD Kidney Transplants Table 5.11b(31 k)
5.11c Unadjusted Graft Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Deceased Donor Kidney Transplants Table 5.11c(30 k)
5.11d Unadjusted Graft Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Living Donor Kidney Transplants Table 5.11d(30 k)
5.12a Adjusted Patient Survival, Deceased Donor non-ECD Kidney Transplants Survival at 3 Months, 1 Year, 5 Years, and 10 Years Table 5.12a(59 k)
Age
Gender
Race
Diagnosis
State of Center
5.12b Adjusted Patient Survival, Deceased Donor ECD Kidney Transplants Survival at 3 Months, 1 Year, 5 Years, and 10 Years Table 5.12b(59 k)
Age
Gender
Race
Diagnosis
State of Center
5.12c Adjusted Patient Survival, Deceased Donor Kidney Transplants Survival at 3 Months, 1 Year, 5 Years, and 10 Years Table 5.12c(58 k)
Age
Gender
Race
Diagnosis
State of Center
5.12d Adjusted Patient Survival, Living Donor Kidney Transplants Survival at 3 Months, 1 Year, 5 Years, and 10 Years Table 5.12d(58 k)
Age
Gender
Race
Diagnosis
State of Center
5.13a Adjusted Patient Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Deceased Donor non-ECD Kidney Transplants Table 5.13a(31 k)
5.13b Adjusted Patient Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Deceased Donor ECD Kidney Transplants Table 5.13b(31 k)
5.13c Adjusted Patient Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Deceased Donor Kidney Transplants Table 5.13c(30 k)
5.13d Adjusted Patient Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Living Donor Kidney Transplants Table 5.13d(30 k)
5.14a Unadjusted Patient Survival, Deceased Donor non-ECD Kidney Transplants Survival at 3 Months, 1 Year, 5 Years, and 10 Years Table 5.14a(103 k)
Age
Blood Type
Residency
Gender
PRA
Race
Center Volume
Donor Age
Diagnosis
Dialysis Within 1 Week of Tx
Cold Ischemic Time
On Life Support at Tx
Hospitalized at Tx
Level of HLA Mismatch
State of Center
5.14b Unadjusted Patient Survival, Deceased Donor ECD Kidney Transplants Survival at 3 Months, 1 Year, 5 Years, and 10 Years Table 5.14b(70 k)
Age
Blood Type
Residency
Gender
PRA
Race
Center Volume
Donor Age
Diagnosis
Dialysis Within 1 Week of Tx
Cold Ischemic Time
On Life Support at Tx
Hospitalized at Tx
Level of HLA Mismatch
State of Center
5.14c Unadjusted Patient Survival, Deceased Donor Kidney Transplants Survival at 3 Months, 1 Year, 5 Years, and 10 Years Table 5.14c(94 k)
Age
Blood Type
Residency
Gender
PRA
Race
Center Volume
Donor Age
Diagnosis
Dialysis Within 1 Week of Tx
Cold Ischemic Time
On Life Support at Tx
Hospitalized at Tx
Level of HLA Mismatch
State of Center
5.14d Unadjusted Patient Survival, Living Donor Kidney Transplants Survival at 3 Months, 1 Year, 5 Years, and 10 Years Table 5.14d(91 k)
Age
Blood Type
Residency
Gender
PRA
Race
Center Volume
Donor Relation
Donor Age
Diagnosis
Dialysis Within 1 Week of Tx
On Life Support at Tx
Hospitalized at Tx
Level of HLA Mismatch
State of Center
5.15a Unadjusted Patient Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Deceased Donor non-ECD Kidney Transplants Table 5.15a(31 k)
5.15b Unadjusted Patient Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Deceased Donor ECD Kidney Transplants Table 5.15b(31 k)
5.15c Unadjusted Patient Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Deceased Donor Kidney Transplants Table 5.15c(30 k)
5.15d Unadjusted Patient Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Living Donor Kidney Transplants Table 5.15d(30 k)
5.16 Prevalence of People Living with a Functioning Transplant at End of Year Kidney Recipients, 1998 to 2006 Table 5.16(106 k)
Blood Type
Residency
Gender
PRA
Race
Donor Type
Age
Diagnosis
Hospitalized at Tx
Level of HLA Mismatch
PRA
Previous Transplant Same Organ
Previous Transplant Any Organ
5.17 Transplants by State and Transplant Center, 1998 to 2007 Kidney Table 5.17(122 k)

Section VI
6.1a Waiting List Patient Characteristics at End of Year Pancreas Transplant Alone (PTA) Waiting List Active Waitlist Patients, 1998 to 2007 Table 6.1a(50 k)
Age
Blood Type
Residency
Gender
Previous Transplant Any Organ
Race
Previous Transplant Same Organ
Time on Waiting List
6.1b Waiting List Patient Characteristics at End of Year Pancreas Transplant Alone (PTA) Waiting List Inactive Waitlist Patients, 1998 to 2007 Table 6.1b(50 k)
Age
Blood Type
Residency
Gender
Previous Transplant Any Organ
Race
Previous Transplant Same Organ
Time on Waiting List
6.2 Time to Transplant, 1998 to 2007 New Pancreas Transplant Alone (PTA) Waiting List Registrations Table 6.2(112 k)
Blood Type
Age
Gender
All Patient Types
Previous Transplant Any Organ
Race
Residency
State of Center
6.3 Reported Deaths and Annual Death Rates Per 1,000 Patient-Years at Risk, 1998 to 2007 Pancreas Transplant Alone (PTA) Waiting List Table 6.3(54 k)
Age
Blood Type
Gender
Race
6.4 Transplant Recipient Characteristics, 1998 to 2007 Pancreas Transplant Alone (PTA) Recipients Table 6.4(52 k)
Age
Blood Type
Residency
Gender
Race
Cold Ischemic Time
Hospitalized at Tx
Previous Transplant Same Organ
Previous Transplant Any Organ
Payment Source
6.5 Incidence of Transplant, 1998 to 2007 Pancreas Transplant Alone (PTA) Transplants per 1 Million Population Table 6.5(141 k)
6.6a Immunosuppression Use for Induction, 1998 to 2007 Recipients with Pancreas Transplant Alone (PTA) Transplants Table 6.6a(61 k)
6.6b Immunosuppression Use for Induction by Discharge Regimen, 2003 to 2007 Recipients with Pancreas Transplant Alone (PTA) Transplants Table 6.6b(39 k)
6.6c Immunosuppression Use for Induction by Steroid Use at Discharge, 2003 to 2007 Recipients with Pancreas Transplant Alone (PTA) Transplants Table 6.6c(37 k)
6.6d Immunosuppression Use for Maintenance by Regimen Prior to Discharge, 1998 to 2007 Recipients with Pancreas Transplant Alone (PTA) Transplants Table 6.6d(37 k)
6.6e Immunosuppression Use for Maintenance Prior to Discharge, 1998 to 2007 Recipients with Pancreas Transplant Alone (PTA) Transplants Table 6.6e(38 k)
6.6f Immunosuppression Use for Maintenance by Regimen One Year Following Transplantation, 1997 to 2006 Recipients with Pancreas Transplant Alone (PTA) Transplants Table 6.6f(38 k)
6.6g Immunosuppression Use for Maintenance Between Discharge and One Year Following Transplantation, 1997 to 2006 Recipients with Pancreas Transplant Alone (PTA) Transplants Table 6.6g(38 k)
6.6h Persistency of Discharge Regimen by Follow-up Period, 2002 to 2006 Recipients with Pancreas Transplant Alone (PTA) Transplants Table 6.6h(138 k)
6.6i Immunosuppression Use for Antirejection Treatment from Transplant to One Year Following Transplantation, 1997 to 2006 Recipients with Pancreas Transplant Alone (PTA) Transplants Table 6.6i(47 k)
6.7 Patients and Annual Death Rates Per 1,000 Patient-Years at Risk, 1998 to 2006 Rates for Recipients during First Year after Pancreas Transplant Alone (PTA) Transplantation Table 6.7(124 k)
Blood Type
Residency
Gender
Race
Donor Age
Previous Transplant
Age
Cold Ischemic Time
Hospitalized at Tx
Level of HLA Mismatch
State of Center
6.8 Adjusted Graft Survival, Pancreas Transplant Alone (PTA) Transplants Survival at 3 Months, 1 Year, 5 Years, and 10 Years Table 6.8(39 k)
Age
Gender
Race
6.9 Adjusted Graft Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Pancreas Transplant Alone (PTA) Transplants Table 6.9(30 k)
6.10 Unadjusted Graft Survival, Pancreas Transplant Alone (PTA) Transplants Survival at 3 Months, 1 Year, 5 Years, and 10 Years Table 6.10(56 k)
Age
Blood Type
Residency
Gender
Race
Center Volume
Donor Age
Cold Ischemic Time
Hospitalized at Tx
Level of HLA Mismatch
State of Center
6.11 Unadjusted Graft Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Pancreas Transplant Alone (PTA) Transplants Table 6.11(30 k)
6.12 Adjusted Patient Survival, Pancreas Transplant Alone (PTA) Transplants Survival at 3 Months, 1 Year, 5 Years, and 10 Years Table 6.12(38 k)
Age
Gender
Race
6.13 Adjusted Patient Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Pancreas Transplant Alone (PTA) Transplants Table 6.13(30 k)
6.14 Unadjusted Patient Survival, Pancreas Transplant Alone (PTA) Transplants Survival at 3 Months, 1 Year, 5 Years, and 10 Years Table 6.14(56 k)
Age
Blood Type
Residency
Gender
Race
Center Volume
Donor Age
Cold Ischemic Time
Hospitalized at Tx
Level of HLA Mismatch
State of Center
6.15 Unadjusted Patient Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Pancreas Transplant Alone (PTA) Transplants Table 6.15(30 k)
6.16 Prevalence of People Living with a Functioning Transplant at End of Year Pancreas Transplant Alone (PTA) Recipients, 1998 to 2006 Table 6.16(48 k)
Blood Type
Residency
Gender
Race
Age
Hospitalized at Tx
Previous Transplant Same Organ
Previous Transplant Any Organ
6.17 Transplants by State and Transplant Center, 1998 to 2007 Pancreas Transplant Alone (PTA) Table 6.17(180 k)

Section VII
7.1a Waiting List Patient Characteristics at End of Year Pancreas After Kidney (PAK) Waiting List Active Waitlist Patients, 1998 to 2007 Table 7.1a(49 k)
Age
Blood Type
Residency
Gender
Race
Previous Transplant Same Organ
Time on Waiting List
7.1b Waiting List Patient Characteristics at End of Year Pancreas After Kidney (PAK) Waiting List Inactive Waitlist Patients, 1998 to 2007 Table 7.1b(49 k)
Age
Blood Type
Residency
Gender
Race
Previous Transplant Same Organ
Time on Waiting List
7.2 Time to Transplant, 1998 to 2007 New Pancreas After Kidney (PAK) Waiting List Registrations Table 7.2(112 k)
Blood Type
Age
Gender
All Patient Types
Race
Residency
State of Center
7.3 Reported Deaths and Annual Death Rates Per 1,000 Patient-Years at Risk, 1998 to 2007 Pancreas After Kidney (PAK) Waiting List Table 7.3(53 k)
Age
Blood Type
Gender
Race
7.4 Transplant Recipient Characteristics, 1998 to 2007 Pancreas After Kidney (PAK) Recipients Table 7.4(51 k)
Age
Blood Type
Residency
Gender
Race
Cold Ischemic Time
Hospitalized at Tx
Previous Transplant Same Organ
Payment Source
7.5 Incidence of Transplant, 1998 to 2007 Pancreas After Kidney (PAK) Transplants per 1 Million Population Table 7.5(141 k)
7.6a Immunosuppression Use for Induction, 1998 to 2007 Recipients with Pancreas After Kidney (PAK) Transplants Table 7.6a(61 k)
7.6b Immunosuppression Use for Induction by Discharge Regimen, 2003 to 2007 Recipients with Pancreas After Kidney (PAK) Transplants Table 7.6b(39 k)
7.6c Immunosuppression Use for Induction by Steroid Use at Discharge, 2003 to 2007 Recipients with Pancreas After Kidney (PAK) Transplants Table 7.6c(37 k)
7.6d Immunosuppression Use for Maintenance by Regimen Prior to Discharge, 1998 to 2007 Recipients with Pancreas After Kidney (PAK) Transplants Table 7.6d(37 k)
7.6e Immunosuppression Use for Maintenance Prior to Discharge, 1998 to 2007 Recipients with Pancreas After Kidney (PAK) Transplants Table 7.6e(54 k)
7.6f Immunosuppression Use for Maintenance by Regimen One Year Following Transplantation, 1997 to 2006 Recipients with Pancreas After Kidney (PAK) Transplants Table 7.6f(38 k)
7.6g Immunosuppression Use for Maintenance Between Discharge and One Year Following Transplantation, 1997 to 2006 Recipients with Pancreas After Kidney (PAK) Transplants Table 7.6g(61 k)
7.6h Persistency of Discharge Regimen by Follow-up Period, 2002 to 2006 Recipients with Pancreas After Kidney (PAK) Transplants Table 7.6h(152 k)
7.6i Immunosuppression Use for Antirejection Treatment from Transplant to One Year Following Transplantation, 1997 to 2006 Recipients with Pancreas After Kidney (PAK) Transplants Table 7.6i(63 k)
7.7 Patients and Annual Death Rates Per 1,000 Patient-Years at Risk, 1998 to 2006 Rates for Recipients during First Year after Pancreas After Kidney (PAK) Transplantation Table 7.7(123 k)
Blood Type
Residency
Gender
Race
Donor Age
Age
Cold Ischemic Time
Hospitalized at Tx
Level of HLA Mismatch
State of Center
7.8 Adjusted Graft Survival, Pancreas After Kidney (PAK) Transplants Survival at 3 Months, 1 Year, 5 Years, and 10 Years Table 7.8(38 k)
Age
Gender
Race
7.9 Adjusted Graft Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Pancreas After Kidney (PAK) Transplants Table 7.9(30 k)
7.10 Unadjusted Graft Survival, Pancreas After Kidney (PAK) Transplants Survival at 3 Months, 1 Year, 5 Years, and 10 Years Table 7.10(63 k)
Age
Blood Type
Residency
Gender
Race
Center Volume
Donor Age
Cold Ischemic Time
Hospitalized at Tx
Level of HLA Mismatch
State of Center
7.11 Unadjusted Graft Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Pancreas After Kidney (PAK) Transplants Table 7.11(30 k)
7.12 Adjusted Patient Survival, Pancreas After Kidney (PAK) Transplants Survival at 3 Months, 1 Year, 5 Years, and 10 Years Table 7.12(38 k)
Age
Gender
Race
7.13 Adjusted Patient Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Pancreas After Kidney (PAK) Transplants Table 7.13(30 k)
7.14 Unadjusted Patient Survival, Pancreas After Kidney (PAK) Transplants Survival at 3 Months, 1 Year, 5 Years, and 10 Years Table 7.14(62 k)
Age
Blood Type
Residency
Gender
Race
Center Volume
Donor Age
Cold Ischemic Time
Hospitalized at Tx
Level of HLA Mismatch
State of Center
7.15 Unadjusted Patient Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Pancreas After Kidney (PAK) Transplants Table 7.15(30 k)
7.16 Prevalence of People Living with a Functioning Transplant at End of Year Pancreas After Kidney (PAK) Recipients, 1998 to 2006 Table 7.16(48 k)
Blood Type
Residency
Gender
Race
Age
Hospitalized at Tx
Previous Transplant Same Organ
7.17 Transplants by State and Transplant Center, 1998 to 2007 Pancreas After Kidney (PAK) Table 7.17(199 k)

Section VIII
8.1a Waiting List Patient Characteristics at End of Year Kidney-Pancreas Waiting List Active Waitlist Patients, 1998 to 2007 Table 8.1a(50 k)
Age
Blood Type
Residency
Gender
Previous Transplant Any Organ
Race
Previous Transplant Same Organ
Time on Waiting List
8.1b Waiting List Patient Characteristics at End of Year Kidney-Pancreas Waiting List Inactive Waitlist Patients, 1998 to 2007 Table 8.1b(50 k)
Age
Blood Type
Residency
Gender
Previous Transplant Any Organ
Race
Previous Transplant Same Organ
Time on Waiting List
8.2 Time to Transplant, 1998 to 2007 New Kidney-Pancreas Waiting List Registrations Table 8.2(165 k)
Blood Type
Age
Gender
All Patient Types
Previous Transplant Any Organ
Race
Residency
State of Center
8.3 Reported Deaths and Annual Death Rates Per 1,000 Patient-Years at Risk, 1998 to 2007 Kidney-Pancreas Waiting List Table 8.3(54 k)
Age
Blood Type
Gender
Race
8.4 Transplant Recipient Characteristics, 1998 to 2007 Kidney-Pancreas Recipients Table 8.4(111 k)
Age
Blood Type
Residency
Gender
Race
Cold Ischemic Time
Hospitalized at Tx
Level of HLA Mismatch
PRA
Previous Transplant Same Organ
Previous Transplant Any Organ
Payment Source
8.5 Incidence of Transplant, 1998 to 2007 Kidney-Pancreas Transplants per 1 Million Population Table 8.5(142 k)
8.6a Immunosuppression Use for Induction, 1998 to 2007 Recipients with Kidney-Pancreas Transplants Table 8.6a(61 k)
8.6b Immunosuppression Use for Induction by Discharge Regimen, 2003 to 2007 Recipients with Kidney-Pancreas Transplants Table 8.6b(49 k)
8.6c Immunosuppression Use for Induction by Steroid Use at Discharge, 2003 to 2007 Recipients with Kidney-Pancreas Transplants Table 8.6c(37 k)
8.6d Immunosuppression Use for Maintenance by Regimen Prior to Discharge, 1998 to 2007 Recipients with Kidney-Pancreas Transplants Table 8.6d(37 k)
8.6e Immunosuppression Use for Maintenance Prior to Discharge, 1998 to 2007 Recipients with Kidney-Pancreas Transplants Table 8.6e(58 k)
8.6f Immunosuppression Use for Maintenance by Regimen One Year Following Transplantation, 1997 to 2006 Recipients with Kidney-Pancreas Transplants Table 8.6f(38 k)
8.6g Immunosuppression Use for Maintenance Between Discharge and One Year Following Transplantation, 1997 to 2006 Recipients with Kidney-Pancreas Transplants Table 8.6g(61 k)
8.6h Persistency of Discharge Regimen by Follow-up Period, 2002 to 2006 Recipients with Kidney-Pancreas Transplants Table 8.6h(69 k)
8.6i Immunosuppression Use for Antirejection Treatment from Transplant to One Year Following Transplantation, 1997 to 2006 Recipients with Kidney-Pancreas Transplants Table 8.6i(50 k)
8.7 Patients and Annual Death Rates Per 1,000 Patient-Years at Risk, 1998 to 2006 Rates for Recipients during First Year after Kidney-Pancreas Transplantation Table 8.7(146 k)
Blood Type
Residency
Gender
PRA
Race
Donor Age
Previous Transplant
Age
Cold Ischemic Time
Hospitalized at Tx
Level of HLA Mismatch
Previous Kidney Transplant
Previous Pancreas Transplant
State of Center
8.8 Adjusted Graft Survival, Kidney-Pancreas Transplants Survival at 3 Months, 1 Year, 5 Years, and 10 Years Table 8.8(45 k)
Kidney Graft - by Age
Pancreas Graft - by Age
Kidney Graft - by Gender
Pancreas Graft - by Gender
Kidney Graft - by Race
Pancreas Graft - by Race
8.9a Adjusted Graft Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Kidney-Pancreas Transplants - Kidney Graft Table 8.9a(30 k)
8.9b Adjusted Graft Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Kidney-Pancreas Transplants - Pancreas Graft Table 8.9b(30 k)
8.10 Unadjusted Graft Survival, Kidney-Pancreas Transplants Survival at 3 Months, 1 Year, 5 Years, and 10 Years Table 8.10(132 k)
Kidney Graft - by Age
Pancreas Graft - by Age
Kidney Graft - by Blood Type
Pancreas Graft - by Blood Type
Kidney Graft - by Residency
Pancreas Graft - by Residency
Kidney Graft - by Gender
Pancreas Graft - by Gender
Kidney Graft - by PRA
Pancreas Graft - by PRA
Kidney Graft - by Race
Pancreas Graft - by Race
Kidney Graft - by Center Volume
Pancreas Graft - by Center Volume
Kidney Graft - by Donor Age
Pancreas Graft - by Donor Age
Previous Transplant Same Organ Kidney Graft
Previous Transplant Same Organ Pancreas Graft
Kidney Graft - by Cold Ischemic Time
Kidney Graft - by Hospitalized at Tx
Pancreas Graft - by Hospitalized at Tx
Kidney Graft - by Level of HLA Mismatch
Pancreas Graft - by Level of HLA Mismatch
Kidney Graft - by Previous Kidney Transplant
Pancreas Graft - by Previous Kidney Transplant
Kidney Graft - by Previous Pancreas Transplant
Pancreas Graft - by Previous Pancreas Transplant
Kidney Graft - by State of Center
Pancreas Graft - by State of Center
8.11a Unadjusted Graft Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Kidney-Pancreas Transplants - Kidney Graft Table 8.11a(30 k)
8.11b Unadjusted Graft Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Kidney-Pancreas Transplants - Pancreas Graft Table 8.11b(30 k)
8.12 Adjusted Patient Survival, Kidney-Pancreas Transplants Survival at 3 Months, 1 Year, 5 Years, and 10 Years Table 8.12(38 k)
Age
Gender
Race
8.13 Adjusted Patient Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Table 8.13(30 k)
8.14 Unadjusted Patient Survival, Kidney-Pancreas Transplants Survival at 3 Months, 1 Year, 5 Years, and 10 Years Table 8.14(83 k)
Age
Blood Type
Residency
Gender
PRA
Race
Center Volume
Donor Age
Cold Ischemic Time
Hospitalized at Tx
Level of HLA Mismatch
State of Center
8.15 Unadjusted Patient Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Table 8.15(30 k)
8.16 Prevalence of People Living with a Functioning Transplant at End of Year Kidney-Pancreas Recipients, 1998 to 2006 Table 8.16(60 k)
Blood Type
Residency
Gender
Race
Age
Hospitalized at Tx
Level of HLA Mismatch
PRA
Previous Transplant Same Organ
Previous Transplant Any Organ
8.17 Transplants by State and Transplant Center, 1998 to 2007 Kidney-Pancreas Table 8.17(96 k)

Section IX
9.1a Waiting List Patient Characteristics at End of Year Liver Waiting List Active Waitlist Patients, 1998 to 2007 Table 9.1a(66 k)
Age
Blood Type
Residency
Diagnosis
Gender
Previous Transplant Any Organ
Race
Patient Status
Previous Transplant Same Organ
Time on Waiting List
9.1b Waiting List Patient Characteristics at End of Year Liver Waiting List Inactive Waitlist Patients, 1998 to 2007 Table 9.1b(56 k)
Age
Blood Type
Residency
Diagnosis
Gender
Previous Transplant Any Organ
Race
Previous Transplant Same Organ
Time on Waiting List
9.2a Events 7 & 15 Days After Listing 2006 and 2007 Liver Registrations with Initial Status 1 Table 9.2a(27 k)
9.2b Events 30 Days After Snapshot of Prevalent Waiting List Adult Patients on Liver Waiting List on Jan. 1, 2007 Table 9.2b(48 k)
30 Days After Snapshot
60 Days After Snapshot
90 Days After Snapshot
9.2c Events 30 Days After Snapshot of Prevalent Waiting List Pediatric Patients on Liver Waiting List on Jan. 1, 2007 Table 9.2c(47 k)
30 Days After Snapshot
60 Days After Snapshot
90 Days After Snapshot
9.3 Reported Deaths and Annual Death Rates Per 1,000 Patient-Years at Risk, 1998 to 2007 Liver Waiting List Table 9.3(93 k)
Age
Blood Type
Diagnosis
Gender
Race
Patient Status
9.4a Transplant Recipient Characteristics, 1998 to 2007 Recipients of Deceased Donor Livers Table 9.4a(70 k)
Age
Blood Type
Residency
Gender
Patient Status
Race
Diagnosis
Cold Ischemic Time
On Life Support at Tx
Hospitalized at Tx
Previous Transplant Same Organ
Previous Transplant Any Organ
Payment Source
Procedure Type
9.4b Transplant Recipient Characteristics, 1998 to 2007 Recipients of Living Donor Livers Table 9.4b(69 k)
Age
Blood Type
Residency
Gender
Patient Status
Race
Donor Relation
Diagnosis
On Life Support at Tx
Hospitalized at Tx
Previous Transplant Same Organ
Previous Transplant Any Organ
Payment Source
9.5 Incidence of Transplant, 1998 to 2007 Liver Transplants per 1 Million Population Table 9.5(141 k)
9.6a Immunosuppression Use for Induction, 1998 to 2007 Recipients with Liver Transplants Table 9.6a(61 k)
9.6b Immunosuppression Use for Induction by Discharge Regimen, 2003 to 2007 Recipients with Liver Transplants Table 9.6b(49 k)
9.6c Immunosuppression Use for Induction by Steroid Use at Discharge, 2003 to 2007 Recipients with Liver Transplants Table 9.6c(37 k)
9.6d Immunosuppression Use for Maintenance by Regimen Prior to Discharge, 1998 to 2007 Recipients with Liver Transplants Table 9.6d(37 k)
9.6e Immunosuppression Use for Maintenance Prior to Discharge, 1998 to 2007 Recipients with Liver Transplants Table 9.6e(51 k)
9.6f Immunosuppression Use for Maintenance by Regimen One Year Following Transplantation, 1997 to 2006 Recipients with Liver Transplants Table 9.6f(39 k)
9.6g Immunosuppression Use for Maintenance Between Discharge and One Year Following Transplantation, 1997 to 2006 Recipients with Liver Transplants Table 9.6g(61 k)
9.6h Persistency of Discharge Regimen by Follow-up Period, 2002 to 2006 Recipients with Liver Transplants Table 9.6h(69 k)
9.6i Immunosuppression Use for Antirejection Treatment from Transplant to One Year Following Transplantation, 1997 to 2006 Recipients with Liver Transplants Table 9.6i(63 k)
9.7a Patients and Annual Death Rates Per 1,000 Patient-Years at Risk, 1998 to 2006 Rates for Recipients during First Year after Deceased Donor Liver Transplantation Table 9.7a(214 k)
Blood Type
Residency
Gender
Patient Status
Race
Donor Age
Previous Transplant
Age
Cold Ischemic Time
On Life Support at Tx
Hospitalized at Tx
Diagnosis
State of Center
9.7b Patients and Annual Death Rates Per 1,000 Patient-Years at Risk, 1998 to 2006 Rates for Recipients during First Year after Living Donor Liver Transplantation Table 9.7b(150 k)
Blood Type
Residency
Gender
Patient Status
Race
Donor Age
Previous Transplant
Age
On Life Support at Tx
Hospitalized at Tx
Diagnosis
State of Center
9.8a Adjusted Graft Survival, Deceased Donor Liver Transplants Survival at 3 Months, 1 Year, 5 Years, and 10 Years Table 9.8a(57 k)
Age
Gender
Race
Diagnosis
State of Center
9.8b Adjusted Graft Survival, Living Donor Liver Transplants Survival at 3 Months, 1 Year, 5 Years, and 10 Years Table 9.8b(56 k)
Age
Gender
Race
Diagnosis
State of Center
9.9a Adjusted Graft Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Deceased Donor Liver Transplants Table 9.9a(30 k)
9.9b Adjusted Graft Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Living Donor Liver Transplants Table 9.9b(30 k)
9.10a Unadjusted Graft Survival, Deceased Donor Liver Transplants Survival at 3 Months, 1 Year, 5 Years, and 10 Years Table 9.10a(73 k)
Age
Blood Type
Residency
Gender
Patient Status
Race
Center Volume
Donor Age
Previous Transplant Same Organ
Diagnosis
Cold Ischemic Time
On Life Support at Tx
Hospitalized at Tx
State of Center
9.10b Unadjusted Graft Survival, Living Donor Liver Transplants Survival at 3 Months, 1 Year, 5 Years, and 10 Years Table 9.10b(72 k)
Age
Blood Type
Residency
Gender
Patient Status
Race
Center Volume
Donor Relation
Donor Age
Previous Transplant Same Organ
Diagnosis
On Life Support at Tx
Hospitalized at Tx
State of Center
9.11a Unadjusted Graft Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Deceased Donor Liver Transplants Table 9.11a(30 k)
9.11b Unadjusted Graft Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Living Donor Liver Transplants Table 9.11b(30 k)
9.12a Adjusted Patient Survival, Deceased Donor Liver Transplants Survival at 3 Months, 1 Year, 5 Years, and 10 Years Table 9.12a(57 k)
Age
Gender
Race
Diagnosis
State of Center
9.12b Adjusted Patient Survival, Living Donor Liver Transplants Survival at 3 Months, 1 Year, 5 Years, and 10 Years Table 9.12b(56 k)
Age
Gender
Race
Diagnosis
State of Center
9.13a Adjusted Patient Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Deceased Donor Liver Transplants Table 9.13a(30 k)
9.13b Adjusted Patient Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Living Donor Liver Transplants Table 9.13b(30 k)
9.14a Unadjusted Patient Survival, Deceased Donor Liver Transplants Survival at 3 Months, 1 Year, 5 Years, and 10 Years Table 9.14a(72 k)
Age
Blood Type
Residency
Gender
Patient Status
Race
Center Volume
Donor Age
Diagnosis
Cold Ischemic Time
On Life Support at Tx
Hospitalized at Tx
State of Center
9.14b Unadjusted Patient Survival, Living Donor Liver Transplants Survival at 3 Months, 1 Year, 5 Years, and 10 Years Table 9.14b(72 k)
Age
Blood Type
Residency
Gender
Patient Status
Race
Center Volume
Donor Relation
Donor Age
Diagnosis
On Life Support at Tx
Hospitalized at Tx
State of Center
9.15a Unadjusted Patient Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Deceased Donor Liver Transplants Table 9.15a(30 k)
9.15b Unadjusted Patient Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Living Donor Liver Transplants Table 9.15b(30 k)
9.16 Prevalence of People Living with a Functioning Transplant at End of Year Liver Recipients, 1998 to 2006 Table 9.16(92 k)
Blood Type
Residency
Gender
Patient Status
Race
Donor Type
Age
Diagnosis
On Life Support at Tx
Hospitalized at Tx
Previous Transplant Same Organ
Previous Transplant Any Organ
9.17 Transplants by State and Transplant Center, 1998 to 2007 Liver Table 9.17(91 k)

Section X
10.1a Waiting List Patient Characteristics at End of Year Intestine Waiting List Active Waitlist Patients, 1998 to 2007 Table 10.1a(55 k)
Age
Blood Type
Residency
Diagnosis
Gender
Previous Transplant Any Organ
Race
Previous Transplant Same Organ
Time on Waiting List
10.1b Waiting List Patient Characteristics at End of Year Intestine Waiting List Inactive Waitlist Patients, 1998 to 2007 Table 10.1b(54 k)
Age
Blood Type
Residency
Diagnosis
Gender
Previous Transplant Any Organ
Race
Previous Transplant Same Organ
Time on Waiting List
10.2 Time to Transplant, 1998 to 2007 New Intestine Waiting List Registrations Table 10.2(97 k)
Blood Type
Age
Gender
All Patient Types
Previous Transplant Any Organ
Race
Residency
State of Center
10.3 Reported Deaths and Annual Death Rates Per 1,000 Patient-Years at Risk, 1998 to 2007 Intestine Waiting List Table 10.3(61 k)
Age
Blood Type
Diagnosis
Gender
Race
10.4 Transplant Recipient Characteristics, 1998 to 2007 Intestine Recipients Table 10.4(57 k)
Age
Blood Type
Residency
Gender
Race
Diagnosis
Cold Ischemic Time
On Life Support at Tx
Hospitalized at Tx
Previous Transplant Same Organ
Previous Transplant Any Organ
Payment Source
10.5 Incidence of Transplant, 1998 to 2007 Intestine Transplants per 1 Million Population Table 10.5(140 k)
10.6a Immunosuppression Use for Induction, 1998 to 2007 Recipients with Intestine Transplants Table 10.6a(61 k)
10.6b Immunosuppression Use for Induction by Discharge Regimen, 2003 to 2007 Recipients with Intestine Transplants Table 10.6b(37 k)
10.6c Immunosuppression Use for Induction by Steroid Use at Discharge, 2003 to 2007 Recipients with Intestine Transplants Table 10.6c(37 k)
10.6d Immunosuppression Use for Maintenance by Regimen Prior to Discharge, 1998 to 2007 Recipients with Intestine Transplants Table 10.6d(36 k)
10.6e Immunosuppression Use for Maintenance Prior to Discharge, 1998 to 2007 Recipients with Intestine Transplants Table 10.6e(37 k)
10.6f Immunosuppression Use for Maintenance by Regimen One Year Following Transplantation, 1997 to 2006 Recipients with Intestine Transplants Table 10.6f(38 k)
10.6g Immunosuppression Use for Maintenance Between Discharge and One Year Following Transplantation, 1997 to 2006 Recipients with Intestine Transplants Table 10.6g(54 k)
10.6h Persistency of Discharge Regimen by Follow-up Period, 2002 to 2006 Recipients with Intestine Transplants Table 10.6h(37 k)
10.6i Immunosuppression Use for Antirejection Treatment from Transplant to One Year Following Transplantation, 1997 to 2006 Recipients with Intestine Transplants Table 10.6i(50 k)
10.7 Patients and Annual Death Rates Per 1,000 Patient-Years at Risk, 1998 to 2006 Rates for Recipients during First Year after Intestine Transplantation Table 10.7(115 k)
Blood Type
Residency
Gender
Race
Donor Age
Previous Transplant
Age
Cold Ischemic Time
On Life Support at Tx
Hospitalized at Tx
Diagnosis
State of Center
10.8 Adjusted Graft Survival, Intestine Transplants Survival at 3 Months, 1 Year, 5 Years, and 10 Years Table 10.8(49 k)
Age
Gender
Race
Diagnosis
State of Center
10.9 Adjusted Graft Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Intestine Transplants Table 10.9(30 k)
10.10 Unadjusted Graft Survival, Intestine Transplants Survival at 3 Months, 1 Year, 5 Years, and 10 Years Table 10.10(62 k)
Age
Blood Type
Residency
Gender
Race
Center Volume
Donor Age
Previous Transplant Same Organ
Diagnosis
Cold Ischemic Time
On Life Support at Tx
Hospitalized at Tx
State of Center
10.11 Unadjusted Graft Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Intestine Transplants Table 10.11(29 k)
10.12 Adjusted Patient Survival, Intestine Transplants Survival at 3 Months, 1 Year, 5 Years, and 10 Years Table 10.12(49 k)
Age
Gender
Race
Diagnosis
State of Center
10.13 Adjusted Patient Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Intestine Transplants Table 10.13(30 k)
10.14 Unadjusted Patient Survival, Intestine Transplants Survival at 3 Months, 1 Year, 5 Years, and 10 Years Table 10.14(62 k)
Age
Blood Type
Residency
Gender
Race
Center Volume
Donor Age
Diagnosis
Cold Ischemic Time
On Life Support at Tx
Hospitalized at Tx
State of Center
10.15 Unadjusted Patient Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Intestine Transplants Table 10.15(29 k)
10.16 Prevalence of People Living with a Functioning Transplant at End of Year Intestine Recipients, 1998 to 2006 Table 10.16(54 k)
Blood Type
Residency
Gender
Race
Age
Diagnosis
On Life Support at Tx
Hospitalized at Tx
Previous Transplant Same Organ
Previous Transplant Any Organ
10.17 Transplants by State and Transplant Center, 1998 to 2007 Intestine Table 10.17(52 k)

Section XI
11.1a Waiting List Patient Characteristics at End of Year Heart Waiting List Active Waitlist Patients, 1998 to 2007 Table 11.1a(57 k)
Age
Blood Type
Residency
Diagnosis
Gender
Previous Transplant Any Organ
Race
Patient Status
Previous Transplant Same Organ
Time on Waiting List
11.1b Waiting List Patient Characteristics at End of Year Heart Waiting List Inactive Waitlist Patients, 1998 to 2007 Table 11.1b(56 k)
Age
Blood Type
Residency
Diagnosis
Gender
Previous Transplant Any Organ
Race
Previous Transplant Same Organ
Time on Waiting List
11.2a Events 7 & 30 Days After Listing 2006 and 2007 Heart Registrations with Initial Status 1A Table 11.2a(26 k)
11.2b Events 30 Days After Snapshot of Prevalent Waiting List Patients on Heart Waiting List on Jan. 1, 2007 Table 11.2b(44 k)
30 Days After Snapshot
60 Days After Snapshot
90 Days After Snapshot
11.3 Reported Deaths and Annual Death Rates Per 1,000 Patient-Years at Risk, 1998 to 2007 Heart Waiting List Table 11.3(67 k)
Age
Blood Type
Diagnosis
Gender
Race
Patient Status
11.4 Transplant Recipient Characteristics, 1998 to 2007 Heart Recipients Table 11.4(63 k)
Age
Blood Type
Residency
Gender
Patient Status
Race
Diagnosis
Cold Ischemic Time
On Life Support at Tx
Hospitalized at Tx
Previous Transplant Same Organ
Previous Transplant Any Organ
Payment Source
Procedure Type
11.5 Incidence of Transplant, 1998 to 2007 Heart Transplants per 1 Million Population Table 11.5(142 k)
11.6a Immunosuppression Use for Induction, 1998 to 2007 Recipients with Heart Transplants Table 11.6a(61 k)
11.6b Immunosuppression Use for Induction by Discharge Regimen, 2003 to 2007 Recipients with Heart Transplants Table 11.6b(49 k)
11.6c Immunosuppression Use for Induction by Steroid Use at Discharge, 2003 to 2007 Recipients with Heart Transplants Table 11.6c(37 k)
11.6d Immunosuppression Use for Maintenance by Regimen Prior to Discharge, 1998 to 2007 Recipients with Heart Transplants Table 11.6d(37 k)
11.6e Immunosuppression Use for Maintenance Prior to Discharge, 1998 to 2007 Recipients with Heart Transplants Table 11.6e(51 k)
11.6f Immunosuppression Use for Maintenance by Regimen One Year Following Transplantation, 1997 to 2006 Recipients with Heart Transplants Table 11.6f(39 k)
11.6g Immunosuppression Use for Maintenance Between Discharge and One Year Following Transplantation, 1997 to 2006 Recipients with Heart Transplants Table 11.6g(51 k)
11.6h Persistency of Discharge Regimen by Follow-up Period, 2002 to 2006 Recipients with Heart Transplants Table 11.6h(55 k)
11.6i Immunosuppression Use for Antirejection Treatment from Transplant to One Year Following Transplantation, 1997 to 2006 Recipients with Heart Transplants Table 11.6i(63 k)
11.7 Patients and Annual Death Rates Per 1,000 Patient-Years at Risk, 1998 to 2006 Rates for Recipients during First Year after Heart Transplantation Table 11.7(174 k)
Blood Type
Residency
Gender
Patient Status
Race
Donor Age
Previous Transplant
Procedure Type
Age
Cold Ischemic Time
On Life Support at Tx
Hospitalized at Tx
Diagnosis
State of Center
11.8 Adjusted Graft Survival, Heart Transplants Survival at 3 Months, 1 Year, 5 Years, and 10 Years Table 11.8(56 k)
Age
Gender
Race
Diagnosis
State of Center
11.9 Adjusted Graft Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Heart Transplants Table 11.9(29 k)
11.10 Unadjusted Graft Survival, Heart Transplants Survival at 3 Months, 1 Year, 5 Years, and 10 Years Table 11.10(85 k)
Age
Blood Type
Residency
Gender
Patient Status
Race
Center Volume
Donor Age
Previous Transplant Same Organ
Procedure Type
Diagnosis
Cold Ischemic Time
On Life Support at Tx
Hospitalized at Tx
State of Center
11.11 Unadjusted Graft Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Heart Transplants Table 11.11(29 k)
11.12 Adjusted Patient Survival, Heart Transplants Survival at 3 Months, 1 Year, 5 Years, and 10 Years Table 11.12(56 k)
Age
Gender
Race
Diagnosis
State of Center
11.13 Adjusted Patient Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Heart Transplants Table 11.13(29 k)
11.14 Unadjusted Patient Survival, Heart Transplants Survival at 3 Months, 1 Year, 5 Years, and 10 Years Table 11.14(70 k)
Age
Blood Type
Residency
Gender
Patient Status
Race
Center Volume
Donor Age
Procedure Type
Diagnosis
Cold Ischemic Time
On Life Support at Tx
Hospitalized at Tx
State of Center
11.15 Unadjusted Patient Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Heart Transplants Table 11.15(29 k)
11.16 Prevalence of People Living with a Functioning Transplant at End of Year Heart Recipients, 1998 to 2006 Table 11.16(78 k)
Blood Type
Residency
Gender
Patient Status
Race
Age
Diagnosis
On Life Support at Tx
Hospitalized at Tx
Previous Transplant Same Organ
Previous Transplant Any Organ
Procedure Type
11.17 Transplants by State and Transplant Center, 1998 to 2007 Heart Table 11.17(92 k)

Section XII
12.1a Waiting List Patient Characteristics at End of Year Lung Waiting List Active Waitlist Patients, 1998 to 2007 Table 12.1a(56 k)
Age
Blood Type
Residency
Diagnosis
Gender
Previous Transplant Any Organ
Race
Previous Transplant Same Organ
Time on Waiting List
12.1b Waiting List Patient Characteristics at End of Year Lung Waiting List Inactive Waitlist Patients, 1998 to 2007 Table 12.1b(56 k)
Age
Blood Type
Residency
Diagnosis
Gender
Previous Transplant Any Organ
Race
Previous Transplant Same Organ
Time on Waiting List
12.2 Time to Transplant, 1998 to 2007 New Lung Waiting List Registrations Table 12.2(105 k)
Blood Type
Age
Gender
All Patient Types
Previous Transplant Any Organ
Race
Residency
State of Center
12.3 Reported Deaths and Annual Death Rates Per 1,000 Patient-Years at Risk, 1998 to 2007 Lung Waiting List Table 12.3(80 k)
Age
Blood Type
Diagnosis
Gender
Race
12.4a Transplant Recipient Characteristics, 1998 to 2007 Recipients of Deceased Donor Lungs Table 12.4a(74 k)
Age
Blood Type
Residency
Gender
Race
Diagnosis
Cold Ischemic Time
On Life Support at Tx
Hospitalized at Tx
Previous Transplant Same Organ
Previous Transplant Any Organ
Payment Source
Procedure Type
12.4b Transplant Recipient Characteristics, 1998 to 2007 Recipients of Living Donor Lungs Table 12.4b(66 k)
Age
Blood Type
Residency
Gender
Race
Donor Relation
Diagnosis
On Life Support at Tx
Hospitalized at Tx
Previous Transplant Same Organ
Previous Transplant Any Organ
Payment Source
Procedure Type
12.5 Incidence of Transplant, 1998 to 2007 Lung Transplants per 1 Million Population Table 12.5(141 k)
12.6a Immunosuppression Use for Induction, 1998 to 2007 Recipients with Lung Transplants Table 12.6a(61 k)
12.6b Immunosuppression Use for Induction by Discharge Regimen, 2003 to 2007 Recipients with Lung Transplants Table 12.6b(49 k)
12.6c Immunosuppression Use for Induction by Steroid Use at Discharge, 2003 to 2007 Recipients with Lung Transplants Table 12.6c(37 k)
12.6d Immunosuppression Use for Maintenance by Regimen Prior to Discharge, 1998 to 2007 Recipients with Lung Transplants Table 12.6d(37 k)
12.6e Immunosuppression Use for Maintenance Prior to Discharge, 1998 to 2007 Recipients with Lung Transplants Table 12.6e(51 k)
12.6f Immunosuppression Use for Maintenance by Regimen One Year Following Transplantation, 1997 to 2006 Recipients with Lung Transplants Table 12.6f(38 k)
12.6g Immunosuppression Use for Maintenance Between Discharge and One Year Following Transplantation, 1997 to 2006 Recipients with Lung Transplants Table 12.6g(51 k)
12.6h Persistency of Discharge Regimen by Follow-up Period, 2002 to 2006 Recipients with Lung Transplants Table 12.6h(138 k)
12.6i Immunosuppression Use for Antirejection Treatment from Transplant to One Year Following Transplantation, 1997 to 2006 Recipients with Lung Transplants Table 12.6i(63 k)
12.7a Patients and Annual Death Rates Per 1,000 Patient-Years at Risk, 1998 to 2006 Rates for Recipients during First Year after Deceased Donor Lung Transplantation Table 12.7a(163 k)
Blood Type
Residency
Gender
Race
Donor Age
Previous Transplant
Procedure Type
Age
Cold Ischemic Time
On Life Support at Tx
Hospitalized at Tx
Diagnosis
State of Center
12.7b Patients and Annual Death Rates Per 1,000 Patient-Years at Risk, 1998 to 2006 Rates for Recipients during First Year after Living Donor Lung Transplantation Table 12.7b(115 k)
Blood Type
Residency
Gender
Race
Donor Age
Previous Transplant
Procedure Type
Age
On Life Support at Tx
Hospitalized at Tx
Diagnosis
State of Center
12.8 Adjusted Graft Survival, Deceased Donor Lung Transplants Survival at 3 Months, 1 Year, 5 Years, and 10 Years Table 12.8(96 k)
Age
Gender
Race
Diagnosis
State of Center
12.9a Adjusted Graft Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Deceased Donor Lung Transplants Table 12.9a(30 k)
12.10a Unadjusted Graft Survival, Deceased Donor Lung Transplants Survival at 3 Months, 1 Year, 5 Years, and 10 Years Table 12.10a(65 k)
Age
Blood Type
Residency
Gender
Race
Center Volume
Donor Age
Previous Transplant Same Organ
Procedure Type
Diagnosis
Cold Ischemic Time
On Life Support at Tx
Hospitalized at Tx
State of Center
12.10b Unadjusted Graft Survival, Living Donor Lung Transplants Survival at 3 Months, 1 Year, 5 Years, and 10 Years Table 12.10b(61 k)
Age
Blood Type
Residency
Gender
Race
Center Volume
Donor Relation
Donor Age
Previous Transplant Same Organ
Diagnosis
On Life Support at Tx
Hospitalized at Tx
State of Center
12.11a Unadjusted Graft Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Deceased Donor Lung Transplants Table 12.11a(30 k)
12.11b Unadjusted Graft Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Living Donor Lung Transplants Table 12.11b(30 k)
12.12 Adjusted Patient Survival, Deceased Donor Lung Transplants Survival at 3 Months, 1 Year, 5 Years, and 10 Years Table 12.12(95 k)
Age
Gender
Race
Diagnosis
State of Center
12.13a Adjusted Patient Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Deceased Donor Lung Transplants Table 12.13a(30 k)
12.14a Unadjusted Patient Survival, Deceased Donor Lung Transplants Survival at 3 Months, 1 Year, 5 Years, and 10 Years Table 12.14a(65 k)
Age
Blood Type
Residency
Gender
Race
Center Volume
Donor Age
Procedure Type
Diagnosis
Cold Ischemic Time
On Life Support at Tx
Hospitalized at Tx
State of Center
12.14b Unadjusted Patient Survival, Living Donor Lung Transplants Survival at 3 Months, 1 Year, 5 Years, and 10 Years Table 12.14b(61 k)
Age
Blood Type
Residency
Gender
Race
Center Volume
Donor Relation
Donor Age
Diagnosis
On Life Support at Tx
Hospitalized at Tx
State of Center
12.15a Unadjusted Patient Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Deceased Donor Lung Transplants Table 12.15a(30 k)
12.15b Unadjusted Patient Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Living Donor Lung Transplants Table 12.15b(30 k)
12.16 Prevalence of People Living with a Functioning Transplant at End of Year Lung Recipients, 1998 to 2006 Table 12.16(58 k)
Blood Type
Residency
Gender
Race
Age
Diagnosis
On Life Support at Tx
Hospitalized at Tx
Previous Transplant Same Organ
Previous Transplant Any Organ
Procedure Type
12.17 Transplants by State and Transplant Center, 1998 to 2007 Lung Table 12.17(70 k)

Section XIII
13.1a Waiting List Patient Characteristics at End of Year Heart-Lung Waiting List Active Waitlist Patients, 1998 to 2007 Table 13.1a(55 k)
Age
Blood Type
Residency
Diagnosis
Gender
Previous Transplant Any Organ
Race
Previous Transplant Same Organ
Time on Waiting List
13.1b Waiting List Patient Characteristics at End of Year Heart-Lung Waiting List Inactive Waitlist Patients, 1998 to 2007 Table 13.1b(55 k)
Age
Blood Type
Residency
Diagnosis
Gender
Previous Transplant Any Organ
Race
Previous Transplant Same Organ
Time on Waiting List
13.2 Time to Transplant, 1998 to 2007 New Heart-Lung Waiting List Registrations Table 13.2(96 k)
Blood Type
Age
Gender
All Patient Types
Previous Transplant Any Organ
Race
Residency
State of Center
13.3 Reported Deaths and Annual Death Rates Per 1,000 Patient-Years at Risk, 1998 to 2007 Heart-Lung Waiting List Table 13.3(62 k)
Age
Blood Type
Diagnosis
Gender
Race
13.4 Transplant Recipient Characteristics, 1998 to 2007 Heart-Lung Recipients Table 13.4(56 k)
Age
Blood Type
Residency
Gender
Race
Diagnosis
On Life Support at Tx
Hospitalized at Tx
Previous Transplant Same Organ
Previous Transplant Any Organ
Payment Source
13.5 Incidence of Transplant, 1998 to 2007 Heart-Lung Transplants per 1 Million Population Table 13.5(140 k)
13.6a Immunosuppression Use for Induction, 1998 to 2007 Recipients with Heart-Lung Transplants Table 13.6a(36 k)
13.6b Immunosuppression Use for Induction by Discharge Regimen, 2003 to 2007 Recipients with Heart-Lung Transplants Table 13.6b(37 k)
13.6c Immunosuppression Use for Induction by Steroid Use at Discharge, 2003 to 2007 Recipients with Heart-Lung Transplants Table 13.6c(37 k)
13.6d Immunosuppression Use for Maintenance by Regimen Prior to Discharge, 1998 to 2007 Recipients with Heart-Lung Transplants Table 13.6d(36 k)
13.6e Immunosuppression Use for Maintenance Prior to Discharge, 1998 to 2007 Recipients with Heart-Lung Transplants Table 13.6e(38 k)
13.6f Immunosuppression Use for Maintenance by Regimen One Year Following Transplantation, 1997 to 2006 Recipients with Heart-Lung Transplants Table 13.6f(38 k)
13.6g Immunosuppression Use for Maintenance Between Discharge and One Year Following Transplantation, 1997 to 2006 Recipients with Heart-Lung Transplants Table 13.6g(51 k)
13.6h Persistency of Discharge Regimen by Follow-up Period, 2002 to 2006 Recipients with Heart-Lung Transplants Table 13.6h(102 k)
13.6i Immunosuppression Use for Antirejection Treatment from Transplant to One Year Following Transplantation, 1997 to 2006 Recipients with Heart-Lung Transplants Table 13.6i(63 k)
13.7 Patients and Annual Death Rates Per 1,000 Patient-Years at Risk, 1998 to 2006 Rates for Recipients during First Year after Heart-Lung Transplantation Table 13.7(116 k)
Blood Type
Residency
Gender
Race
Donor Age
Previous Transplant
Age
Cold Ischemic Time
On Life Support at Tx
Hospitalized at Tx
Diagnosis
State of Center
13.8 Adjusted Graft Survival, Heart-Lung Transplants Survival at 3 Months, 1 Year, 5 Years, and 10 Years Table 13.8(49 k)
Age
Gender
Race
Diagnosis
State of Center
13.9 Adjusted Graft Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Heart-Lung Transplants Table 13.9(30 k)
13.10 Unadjusted Graft Survival, Heart-Lung Transplants Survival at 3 Months, 1 Year, 5 Years, and 10 Years Table 13.10(62 k)
Age
Blood Type
Residency
Gender
Race
Center Volume
Donor Age
Previous Transplant Same Organ
Diagnosis
Cold Ischemic Time
On Life Support at Tx
Hospitalized at Tx
State of Center
13.11 Unadjusted Graft Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Heart-Lung Transplants Table 13.11(30 k)
13.12 Adjusted Patient Survival, Heart-Lung Transplants Survival at 3 Months, 1 Year, 5 Years, and 10 Years Table 13.12(49 k)
Age
Gender
Race
Diagnosis
State of Center
13.13 Adjusted Patient Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Heart-Lung Transplants Table 13.13(30 k)
13.14 Unadjusted Patient Survival, Heart-Lung Transplants Survival at 3 Months, 1 Year, 5 Years, and 10 Years Table 13.14(62 k)
Age
Blood Type
Residency
Gender
Race
Center Volume
Donor Age
Diagnosis
Cold Ischemic Time
On Life Support at Tx
Hospitalized at Tx
State of Center
13.15 Unadjusted Patient Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Heart-Lung Transplants Table 13.15(30 k)
13.16 Prevalence of People Living with a Functioning Transplant at End of Year Heart-Lung Recipients, 1998 to 2006 Table 13.16(54 k)
Blood Type
Residency
Gender
Race
Age
Diagnosis
On Life Support at Tx
Hospitalized at Tx
Previous Transplant Same Organ
Previous Transplant Any Organ
13.17 Transplants by State and Transplant Center, 1998 to 2007 Heart-Lung Table 13.17(138 k)

Section XIV
14.1 History of Cancer among Deceased Donors, 1998 to 2007 Table 14.1(37 k)
14.2 Recipient Recurrence of Pretransplant Malignancies, 1998 to 2007 Table 14.2(90 k)
14.3 Recipient De Novo Posttransplant Solid Malignancies, 1998 to 2007 by Transplant Type Table 14.3(38 k)
14.4 Recipient De Novo Posttransplant Lymphoproliferative Disorders (PTLD), 1998 to 2007 by Transplant Type Table 14.4(38 k)
14.5 History of Cancer among Deceased Kidney Donors 1998 to 2007 Table 14.5(38 k)
14.6 De Novo Posttransplant Solid Malignancy, 1998 to 2007 Kidney Recipients Table 14.6(41 k)
14.7 History of Cancer among Deceased Liver Donors 1998 to 2007 Table 14.7(38 k)
14.8 De Novo Posttransplant Solid Malignancy, 1998 to 2007 Liver Recipients Table 14.8(41 k)
14.9 History of Cancer among Deceased Heart Donors 1998 to 2007 Table 14.9(38 k)
14.10 De Novo Posttransplant Solid Malignancy, 1998 to 2007 Heart Recipients Table 14.10(41 k)

Section XV
15.1 Waiting Time Before Transplant - Excluding Inactive Time, Censored at WL Removal New Waiting List Registrations, 1998 to 2007 Table 15.1(91 k)
15.2 Time to Transplant, 1998 to 2007 New Liver Waiting List Registrations Table 15.2(119 k)
Blood Type
Age
Gender
All Patient Types
Patient Status
Previous Transplant Any Organ
Race
Residency
15.3 Time to Transplant, 1998 to 2007 New Heart Waiting List Registrations Table 15.3(103 k)
Blood Type
Age
Gender
All Patient Types
Patient Status
Previous Transplant Any Organ
Race
Residency
15.4a Steroid Avoidance Rate at Discharge, 1998 to 2007 Recipients of Deceased Donor Kidneys Table 15.4a(51 k)
Steroid Avoidance Rate at Discharge, 1998 to 2007 Recipients of Deceased Donor Kidneys
Steroid Withdrawal Rate at One Year Following Transplantation, 1999 to 2006 Recipients of Deceased Donor Kidneys
Steroid Withdrawal Rate at Two Years Following Transplantation, 1998 to 2005 Recipients of Deceased Donor Kidneys
15.4b Steroid Avoidance Rate at Discharge, 1998 to 2007 Recipients of Living Donor Kidneys Table 15.4b(51 k)
Steroid Avoidance Rate at Discharge, 1998 to 2007 Recipients of Living Donor Kidneys
Steroid Withdrawal Rate at One Year Following Transplantation, 1999 to 2006 Recipients of Living Donor Kidneys
Steroid Withdrawal Rate at Two Years Following Transplantation, 1998 to 2005 Recipients of Living Donor Kidneys
15.5a Steroid Avoidance Rate at Discharge, 1998 to 2007 Recipients of Deceased Donor Livers Table 15.5a(51 k)
Steroid Avoidance Rate at Discharge, 1998 to 2007 Recipients of Deceased Donor Livers
Steroid Withdrawal Rate at One Year Following Transplantation, 1999 to 2006 Recipients of Deceased Donor Livers
Steroid Withdrawal Rate at Two Years Following Transplantation, 1998 to 2005 Recipients of Deceased Donor Livers
15.5b Steroid Avoidance Rate at Discharge, 1998 to 2007 Recipients of Living Donor Livers Table 15.5b(50 k)
Steroid Avoidance Rate at Discharge, 1998 to 2007 Recipients of Living Donor Livers
Steroid Withdrawal Rate at One Year Following Transplantation, 1999 to 2006 Recipients of Living Donor Livers
Steroid Withdrawal Rate at Two Years Following Transplantation, 1998 to 2005 Recipients of Living Donor Livers
15.6 Steroid Avoidance Rate at Discharge, 1998 to 2007 Recipients of Heart Transplants Table 15.6(50 k)
Steroid Avoidance Rate at Discharge, 1998 to 2007 Recipients of Heart Transplants
Steroid Withdrawal Rate at One Year Following Transplantation, 1999 to 2006 Recipients of Heart Transplants
Steroid Withdrawal Rate at Two Years Following Transplantation, 1998 to 2005 Recipients of Heart Transplants
15.7 Immunosuppression Use for Maintenance by Regimen Two Years Following Transplantation, 1998 to 2005 Recipients with Kidney Transplants Table 15.7(38 k)
15.8 Immunosuppression Use for Maintenance by Regimen Two Years Following Transplantation, 1998 to 2005 Recipients with Pancreas Transplant Alone (PTA) Transplants Table 15.8(39 k)
15.9 Immunosuppression Use for Maintenance by Regimen Two Years Following Transplantation, 1998 to 2005 Recipients with Pancreas After Kidney (PAK) Transplants Table 15.9(39 k)
15.10 Immunosuppression Use for Maintenance by Regimen Two Years Following Transplantation, 1998 to 2005 Recipients with Kidney-Pancreas Transplants Table 15.10(39 k)
15.11 Immunosuppression Use for Maintenance by Regimen Two Years Following Transplantation, 1998 to 2005 Recipients with Liver Transplants Table 15.11(39 k)
15.12 Immunosuppression Use for Maintenance by Regimen Two Years Following Transplantation, 1998 to 2005 Recipients with Intestine Transplants Table 15.12(39 k)
15.13 Immunosuppression Use for Maintenance by Regimen Two Years Following Transplantation, 1998 to 2005 Recipients with Heart Transplants Table 15.13(38 k)
15.14 Immunosuppression Use for Maintenance by Regimen Two Years Following Transplantation, 1998 to 2005 Recipients with Lung Transplants Table 15.14(39 k)
15.15 Immunosuppression Use for Maintenance by Regimen Two Years Following Transplantation, 1998 to 2005 Recipients with Heart-Lung Transplants Table 15.15(38 k)


PDF FormatRequires Adobe Acrobat Reader